Method for diagnosing age-related macular degeneration by measuring peripheral blood CRX genes
A macular degeneration and correlation technology, applied in the field of biomedicine, can solve problems such as visual function damage, fundus pathological changes, and limited treatment effect of patients
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0125] Example 1 CRX gene expression analysis
[0126] From the gene expression data set of AMD patient tissues in Iowa, a total of 83 samples (including 42 normal groups, 16 pre-AMD groups, 16 dry-AMD groups, and 9 wet-AMD groups) were obtained through the screening of redundant samples. (Cy5 / Cy3) expression data, and the analysis of differentially expressed genes (t test).
[0127] see results Figure 1-3 , figure 1 The gene expression of CRX in the tissue samples of this study is shown; figure 2 Confidence intervals between CRX gene expression groups in the tissue samples of this study are shown; image 3 The statistical results of the CRX gene expression group in the tissue samples of this study are shown. The CRX gene is differentially down-regulated in the AMD patient group and the normal group (P. value=0.029, fold Change value=-1.177), and in the wet-AMD group and the normal group The expression was differentially down-regulated in the normal group (P. value = 0.0...
Embodiment 2
[0128] Example 2 methylation analysis results
[0129] Corresponding gene expression in retinal or macular retinal pigment epithelium-choroidal tissue from AMD patients to gene expression signatures in blood samples was validated on the methylation dataset in blood tissue samples from John Hopkins University. In the methylation expression data set of John Hopkins University (nine in the AMD group and nine in the normal control group), the eBayes model was used for statistical analysis through de-redundancy and data preprocessing.
[0130] see results Figure 4 . Figure 4 It shows the results of CRX methylation in the blood samples of this study. The promoter region of the CRX gene is hypermethylated, among which TSS200, TSS1500, 1stExon and 5'UTR, 3'UTR, and 5'UTR are differentially hypermethylated , respectively TSS200 (P. value = 0.0173, fold Change value = 0.027), TSS1500 (P. value = 0.0324, fold Change value = 0.0603), 1stExon and 5'UTR (P. value = 0.0142, fold Change v...
Embodiment 3
[0131] Preparation and verification of embodiment 3 kit
[0132] This embodiment provides a kit for detecting the expression of CRX gene. This kit can detect the expression level of CRX gene:
[0133] Kit main reagents:
[0134] (1) Amplification primers: upstream primer (F) and downstream primer (R);
[0135] (2) Main reagents for PCR: Pfu high-fidelity enzyme, 10×PCR Buffer, dNTPMixtur, ddH 2 O;
[0136] (3) Main reagents for gene expression level detection; and / or
[0137] (4) Main reagents for methylation detection.
[0138] The invention has also been tested and validated in a population sample. The results show that the expression level and / or methylation of CRX gene can provide useful auxiliary diagnostic information for age-related macular degeneration, especially for early and / or auxiliary diagnosis.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



